A detailed history of Caldwell Trust CO transactions in Viatris Inc stock. As of the latest transaction made, Caldwell Trust CO holds 304 shares of VTRS stock, worth $3,158. This represents 0.0% of its overall portfolio holdings.

Number of Shares
304
Holding current value
$3,158
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Sep 22, 2025

BUY
$7.26 - $9.12 $2,207 - $2,772
304 New
304 $2.72 Million
Q3 2024

Sep 24, 2025

SELL
$10.32 - $12.13 $2,559 - $3,008
-248 Reduced 46.97%
280 $3.25 Million
Q2 2024

Sep 24, 2025

SELL
$10.05 - $12.02 $793 - $949
-79 Reduced 13.01%
528 $5.61 Million
Q1 2024

Sep 24, 2025

BUY
$11.27 - $13.53 $3,414 - $4,099
303 Added 99.67%
607 $7.25 Million
Q4 2023

Oct 01, 2025

SELL
$8.77 - $10.85 $271 - $336
-31 Reduced 5.75%
508 $5.5 Million
Q3 2023

Oct 01, 2025

SELL
$9.59 - $11.35 $230 - $272
-24 Reduced 4.26%
539 $5.32 Million
Q2 2023

Oct 01, 2025

SELL
$9.02 - $10.29 $405 - $463
-45 Reduced 7.4%
563 $5.62 Million
Q1 2023

Oct 01, 2025

BUY
$9.2 - $12.26 $2,796 - $3,727
304 Added 100.0%
608 $5.85 Million
Q3 2022

Oct 01, 2025

BUY
$8.48 - $11.13 $2,493 - $3,272
294 Added 96.71%
598 $5.1 Million
Q2 2022

Oct 01, 2025

SELL
$9.95 - $12.27 $159 - $196
-16 Reduced 2.21%
708 $7.41 Million
Q1 2022

Oct 01, 2025

BUY
$9.81 - $15.4 $4,120 - $6,468
420 Added 138.16%
724 $7.88 Million
Q4 2021

Oct 02, 2025

SELL
$12.09 - $14.68 $3,336 - $4,051
-276 Reduced 27.6%
724 $9.8 Million
Q3 2021

Oct 02, 2025

SELL
$13.25 - $15.13 $23,094 - $26,371
-1,743 Reduced 63.54%
1,000 $13.6 Million
Q2 2021

Oct 02, 2025

SELL
$12.97 - $16.15 $2,010 - $2,503
-155 Reduced 5.35%
2,743 $39.2 Million
Q1 2021

Oct 02, 2025

BUY
$13.59 - $18.54 $35,252 - $48,092
2,594 Added 853.29%
2,898 $40.5 Million
Q4 2020

Oct 02, 2025

BUY
$14.3 - $18.74 $69,526 - $91,113
4,862 Added 1599.34%
5,166 $96.8 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Caldwell Trust CO Portfolio

Follow Caldwell Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caldwell Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Caldwell Trust CO with notifications on news.